Skip to content
Research Atlas / Field

Maternal and newborn health in low-resource settings

3 questions in the Atlas. 3 still open. Know something we don't? Send us a problem.

In this field

3 questions, strongest case first

  1. In most low-resource labour wards a midwife checks the baby's heartbeat now and then by listening with a Pinard stethoscope or hand-held Doppler; how often, when relative to a contraction, and for how long must she listen to catch the heart-rate drops that warn of a baby short of oxygen?Accepted on a narrowed question: a benchmark, on the open CTU-UHB labour recordings, of what share of labelled late decelerations each common way of intermittent listening catches (WHO single 1-minute count, 60 s after the contraction, ACNM multiple short counts, Sholapurkar 2022), framed for researchers and never as a clinical schedule.
  2. Where in sub-Saharan Africa, and in which months and hours of the day, does filtered sunlight under a tinted canopy deliver enough blue light to treat newborn jaundice, so that clinics without working phototherapy machines know when they can rely on it and when they must refer?Severe newborn jaundice is 'a leading cause of deafness, cerebral palsy, and other neurologic damage among survivors', and 'functional phototherapy devices are often unavailable due to financial constraints' in poor settings (Slusher et al., Pediatrics 2014;133(6):e1568).
  3. How much of the poor-quality oxytocin (the main drug to prevent heavy bleeding after birth) found in low- and middle-income countries is explained by the heat it meets between the factory and the delivery room, and in which places and seasons is it likely to have lost potency by the time it is used?A 2020 review of oxytocin quality (Lambert et al., PMC7227300) reports that a systematic review by Torloni and colleagues found unacceptable oxytocin content in 36% of 559 samples from 15 low- and middle-income countries (the samples were not random), that 'cumulative heat exposure is generally not tracked and leads to degradation', that 'there is no test to assess oxytocin content of the injection products at lower levels of the health system', and that heat-stable carbetocin was not yet available in most of these countries.

Other fields